Australian Cancer Drug that ‘Melts’ Away’ Cancer Cells in Trials Approved for Use in U.S.
A NEW tablet that “melts away” certain blood cancer cells, and has seen one in five end-stage patients cancer-free, has been approved for use in the US. The announcement by the Food and Drug Administration that the drug venetoclax can be prescribed outside clinical trials for a subtype of chronic lymphocytic leukaemia (CLL), is a strong indicator that the drugs … Continue reading